» Articles » PMID: 28427511

Role of Hypoxia-inducible Factors (HIF) in the Maintenance of Stemness and Malignancy of Colorectal Cancer

Overview
Specialty Hematology
Date 2017 Apr 22
PMID 28427511
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Hypoxia is a condition of insufficient tissue oxygenation, which is observed during normal development as well as tumorigenesis and its response at the cellular level is primarily mediated through hypoxia inducible factors (HIFs). HIFs have a significant role in the maintenance of stemness in both stem cells as well as in cancer stem cells (CSC) by acting as transcription factors. The CSCs are proposed to be the driving force of colon tumorigenesis and malignancy. These HIFs play a significant role in a wide range of diseases including colon cancer. HIF's signaling functions with stemness, and maintaining Wnt/β-catenin signaling pathways. Due to HIFs functional significance in stemness maintenance in malignancy, targeting HIFs might provide a new approach for development of new therapy for colon cancer. In this review, we will be briefing on the colon and its stem cells, various molecular signaling pathways involved in stemness preservation, and the role hypoxia and its HIFs in the maintenance of stemness in colon stem cells and colon cancer stem cells.

Citing Articles

A conditionally replicative adenovirus vector containing the synNotch receptor gene for the treatment of muscle-invasive bladder cancer.

A R, Ueki H, Nishioka S, Yamazaki R, Maekawa M, Kitagawa K Cancer Gene Ther. 2025; .

PMID: 40011711 DOI: 10.1038/s41417-025-00879-8.


Hypoxic Signaling Is Modulated by Calcium Channel, CaV1.3, in Androgen-Resistant Prostate Cancer.

OReilly D, Buchanan P Bioelectricity. 2024; 4(2):81-91.

PMID: 39350777 PMC: 11441368. DOI: 10.1089/bioe.2022.0007.


Integrated analysis to identify biological features and molecular markers of poorly cohesive gastric carcinoma (PCC).

Liu Y, Ye Q, Li J, Bai L, Zhang W, Wang S Sci Rep. 2024; 14(1):22596.

PMID: 39349535 PMC: 11442943. DOI: 10.1038/s41598-024-73062-y.


Molecular mechanism of PARP inhibitor resistance.

Huang Y, Chen S, Yao N, Lin S, Zhang J, Xu C Oncoscience. 2024; 11:69-91.

PMID: 39318358 PMC: 11420906. DOI: 10.18632/oncoscience.610.


CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A.

Feng D, Gao J, Liu R, Liu W, Gao T, Yang Y Protein Cell. 2024; 15(10):744-765.

PMID: 38476024 PMC: 11443453. DOI: 10.1093/procel/pwae010.